Gallbladder cancer - 22/08/11
, Hemant M. Kocher, M.D., F.R.C.S. b, Leonardo Solaini, M.D. b, Arvin Yarollahi, M.D. b, Evangelos Tsiambas, M.D. c, Nikolaos S. Salemis, M.D., Ph.D. aAbstract |
Background |
Gallbladder cancer (GC) is a relatively rare but highly lethal neoplasm. We review the epidemiology, etiology, pathology, symptoms, diagnosis, staging, treatment, and prognosis of GC.
Method |
A Pubmed database search between 1971 and February 2007 was performed. All abstracts were reviewed and articles with GC obtained; further references were extracted by hand-searching the bibliography. The database search was done in the English language.
Results |
The accurate etiology of GC remains unclear, while the symptoms associated with primary GC are not specific. Treatment with radical cholecystectomy is curative but possible in only 10% to 30% of patients. For patients whose cancer is an incidental finding on pathologic review, re-resection is indicated, where feasible, for all disease except T1a. Patients with advanced disease should receive palliative treatment. Laparoscopic cholecystectomy is contraindicated in the presence of GC.
Conclusion |
Prognosis generally is extremely poor. Improvements in the outcome of surgical resection have caused this approach to be re-evaluated, while the role of chemotherapy and radiotherapy remains controversial.
Le texte complet de cet article est disponible en PDF.Keywords : Gallbladder cancer, Pathology, Diagnosis, Treatment, Prognosis
Plan
Vol 196 - N° 2
P. 252-264 - août 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
